136 related articles for article (PubMed ID: 24145240)
1. Stem cell self-renewal factors Bmi1 and HMGA2 in head and neck squamous cell carcinoma: clues for diagnosis.
Yamazaki H; Mori T; Yazawa M; Maeshima AM; Matsumoto F; Yoshimoto S; Ota Y; Kaneko A; Tsuda H; Kanai Y
Lab Invest; 2013 Dec; 93(12):1331-8. PubMed ID: 24145240
[TBL] [Abstract][Full Text] [Related]
2. HMGA2-Snai2 axis regulates tumorigenicity and stemness of head and neck squamous cell carcinoma.
Li Z; Wu X; Li J; Yu S; Ke X; Yan T; Zhu Y; Cheng J; Yang J
Exp Cell Res; 2022 Sep; 418(1):113271. PubMed ID: 35764101
[TBL] [Abstract][Full Text] [Related]
3. The Stem Cell Factor HMGA2 Is Expressed in Non-HPV-Associated Head and Neck Squamous Cell Carcinoma and Predicts Patient Survival of Distinct Subsites.
Günther K; Foraita R; Friemel J; Günther F; Bullerdiek J; Nimzyk R; Markowski DN; Behrens T; Ahrens W
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):197-205. PubMed ID: 27742669
[TBL] [Abstract][Full Text] [Related]
4. Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity.
Miyazawa J; Mitoro A; Kawashiri S; Chada KK; Imai K
Cancer Res; 2004 Mar; 64(6):2024-9. PubMed ID: 15026339
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of HMGA2, P16, and HPV in oral squamous cell carcinomas.
Loeschke S; Ohlmann AK; Bräsen JH; Holst R; Warnke PH
J Craniomaxillofac Surg; 2016 Sep; 44(9):1422-9. PubMed ID: 27421171
[TBL] [Abstract][Full Text] [Related]
6. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
7. HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma.
Sakata J; Hirosue A; Yoshida R; Kawahara K; Matsuoka Y; Yamamoto T; Nakamoto M; Hirayama M; Takahashi N; Nakamura T; Arita H; Nakashima H; Nagata M; Hiraki A; Shinohara M; Nakayama H
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109142
[TBL] [Abstract][Full Text] [Related]
8. HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma.
Sterenczak KA; Eckardt A; Kampmann A; Willenbrock S; Eberle N; Länger F; Kleinschmidt S; Hewicker-Trautwein M; Kreipe H; Nolte I; Murua Escobar H; Gellrich NC
BMC Cancer; 2014 Sep; 14():694. PubMed ID: 25245141
[TBL] [Abstract][Full Text] [Related]
9. Altered DNA methylation is associated with aberrant stemness gene expression in early‑stage HNSCC.
Suzuki T; Yamazaki H; Honda K; Ryo E; Kaneko A; Ota Y; Mori T
Int J Oncol; 2019 Oct; 55(4):915-924. PubMed ID: 31432153
[TBL] [Abstract][Full Text] [Related]
10. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.
Hebert C; Norris K; Scheper MA; Nikitakis N; Sauk JJ
Mol Cancer; 2007 Jan; 6():5. PubMed ID: 17222355
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
12. CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.
Ganguli-Indra G; Wasylyk C; Liang X; Millon R; Leid M; Wasylyk B; Abecassis J; Indra AK
PLoS One; 2009; 4(4):e5367. PubMed ID: 19399189
[TBL] [Abstract][Full Text] [Related]
13. HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas.
Palumbo A; De Martino M; Esposito F; Fraggetta F; Neto PN; Valverde Fernandes P; Santos IC; Dias FL; Nasciutti LE; Meireles Da Costa N; Fusco A; Ribeiro Pinto LF
Histopathology; 2018 Jun; 72(7):1102-1114. PubMed ID: 29266325
[TBL] [Abstract][Full Text] [Related]
14. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
17. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.
Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S
Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.
Nör C; Zhang Z; Warner KA; Bernardi L; Visioli F; Helman JI; Roesler R; Nör JE
Neoplasia; 2014 Feb; 16(2):137-46. PubMed ID: 24709421
[TBL] [Abstract][Full Text] [Related]
20. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]